http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004019863-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf9883b568cb715cc8ada12daf167341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf0f68bc9b66c444a1b7b970ce248f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
filingDate 2003-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0092c1607053d60cecf5ef73e08dfc50
publicationDate 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004019863-A3
titleOfInvention Combination therapy for treatment of fibrotic disorders
abstract The present invention provides methods of treating a fibrotic disorder. The methods generally involve administering an effective amount of IFN-γ and an effective amount of pirfenidone or a pirfenidone analog.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9290450-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9114138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8691849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8691813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8697689-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8748621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8937060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946205-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9266834-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722894-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9271967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9132122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9527816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9226930-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359379-B2
priorityDate 2002-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03051388-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5310562-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0328255-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15978
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396991
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109644000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449517
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403801
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512072
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574282
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40632

Total number of triples: 61.